Abiozen’s capabilities in oncology and critical care API manufacturing are engineered to meet the highest standards of precision, safety, and therapeutic efficacy. We specialize in the sterile production of high-potency compounds, including cytotoxic and HPAPIs, within facilities designed for stringent environmental and occupational safety controls.

Targeted Therapeutic Focus

Our portfolio supports a wide range of life-saving applications. We manufacture APIs for targeted cancer therapies, including tyrosine kinase inhibitors, PARP inhibitors, and immune checkpoint modulators that form the backbone of precision oncology. In the immunotherapy space, our APIs enable CAR-T cell therapies, bispecific antibodies, and cytokine-based treatments. We also produce supportive care medications such as pain management agents, antiemetics, and anticoagulants—critical in high-risk, acute care settings.

Operator Safety and Containment Systems

To ensure both operator and product safety, we utilize glovebox isolators and closed-system transfer devices (CSTDs) for safe handling of HPAPIs and cytotoxics. ISO Class 5 cleanrooms, continuous air quality monitoring, and HEPA filtration maintain a sterile production environment, ensuring integrity across every batch.

Compliance and Technical Excellence

Our operations strictly adhere to USFDA, EMA, and ICH guidelines. Inspired by Curia Global’s advanced practices, we maintain dedicated suites for HPAPI production with integrated decontamination and waste management protocols. Automated sterile fill-finish lines further reduce human intervention, ensuring consistent product sterility and precision in packaging and vial filling.